Tocilizumab, Sarilumab and Anakinra in Critically Ill Patients with COVID-19: a Randomised, Controlled, Open-Label, Adaptive Platform Trial.
Lennie Derde, Anthony C Gordon, Paul R Mouncey, Farah Al-Beidh, Kathryn M Rowan, Alistair D Nichol, Yaseen M Arabi, Djillali Annane,Abigail Beane,Richard Beasley, Marc J M Bonten, Charlotte A Bradbury,Frank M Brunkhorst,Adrian Buzgau,Meredith Buxton, Allen C Cheng, Nicola Cooper, Matthew Cove, Olaf L Cremer,Michelle A Detry, Eamon J Duffy, Lise J Estcourt,Mark Fitzgerald, James Galea,Herman Goossens,Rashan Haniffa, Thomas E Hills, David T Huang,Nao Ichihara, Andrew King,François Lamontagne, Patrick R Lawler,Helen L Leavis, Roger J Lewis,Edward Litton, John C Marshall,Florian B Mayr,Daniel F McAuley,Anna McGlothlin, Shay P McGuinness,Bryan J McVerry,Susan C Morpeth,Srinivas Murthy, Mihai G Netea,Kayode Ogungbenro, Katrina Orr, Rachael L Parke, Jane C Parker, Asad E Patanwala,Ville Pettila,Luis Felipe Reyes,Hiroki Saito, Marlene S Santos, Christina T Saunders,Christopher W Seymour,Manu Shankar-Hari, Wendy I Sligl, Alexis F Turgeon, Anne M Turner, Steven Y C Tong, Suvi Vaara, Taryn Youngstein,Ryan Zarychanski,Cameron Green, Alisa M Higgins, Colin J McArthur,Lindsay R Berry, Elizabeth Lorenzi, Scott Berry, Steve A Webb, Derek C Angus, Frank L van de Veerdonk
Thorax（2025）
引用 0|浏览2
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要